Synthesis of Novel Vitamin K₂ Analogues with Modification at the ω-Terminal Position and Their Biological Evaluation as Potent Steroid and Xenobiotic Receptor (SXR) Agonists

Synthesis of Novel Vitamin K₂ Analogues with Modification at the ω-Terminal Position and Their Biological Evaluation as Potent Steroid and Xenobiotic Receptor (SXR) Agonists Synthesis of New Vitamin K Analogues as Steroid and Xenobiotic Receptor (SXR) Agonists: Insights into the Biological Role of the Side Chain Part of Vitamin K Synthesis of 4-(3-biaryl)quinoline sulfones as potent liver X receptor agonists Side-Chain Modified Ergosterol and Stigmasterol Derivatives as Liver X Receptor Agonists Modeling, Synthesis and Biological Evaluation of Potential Retinoid X Receptor (RXR) Selective Agonists: Novel Analogues of 4-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethynyl]benzoic Acid (Bexarotene) 4-(3-Aryloxyaryl)quinoline sulfones are potent liver X receptor agonists 3-(3-Aryloxyaryl)imidazo[1,2-a]pyridine sulfones as liver X receptor agonists 2-(3-Methoxyphenyl)quinazoline Derivatives: A New Class of Direct Constitutive Androstane Receptor (CAR) Agonists 4-(3-Aryloxyaryl)quinoline alcohols are liver X receptor agonists Synthesis and initial biological evaluation of new mimics of the LXR-modulator 22(S)-hydroxycholesterol